Department of Intensive Care Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
Sci Rep. 2024 Feb 27;14(1):4760. doi: 10.1038/s41598-024-55257-5.
Our study aimed to identify the optimal scoring system for predicting the prognosis of patients with sepsis-associated acute respiratory failure (SA-ARF). All data were taken from the fourth version of the Markets in Intensive Care Medicine (MIMIC-IV) database. Independent risk factors for death in hospitals were confirmed by regression analysis. The predictive value of the five scoring systems was evaluated by receiving operating characteristic (ROC) curves. Kaplan‒Meier curves showed the impact of acute physiology score III (APSIII) on survival and prognosis in patients with SA-ARF. Decision curve analysis (DCA) identified a scoring system with the highest net clinical benefit. ROC curve analysis showed that APS III (AUC: 0.755, 95% Cl 0.714-0.768) and Logical Organ Dysfunction System (LODS) (AUC: 0.731, 95% Cl 0.717-0.7745) were better than Simplified Acute Physiology Score II (SAPS II) (AUC: 0.727, 95% CI 0.713-0.741), Oxford Acute Severity of Illness Score (OASIS) (AUC: 0.706, 95% CI 0.691-0.720) and Sequential Organ Failure Assessment (SOFA) (AUC: 0.606, 95% CI 0.590-0.621) in assessing in-hospital mortality. Kaplan‒Meier survival analysis patients in the high-APS III score group had a considerably poorer median survival time. The DCA curve showed that APS III may provide better clinical benefits for patients. We demonstrated that the APS III score is an excellent predictor of in-hospital mortality.
我们的研究旨在确定预测脓毒症相关急性呼吸衰竭(SA-ARF)患者预后的最佳评分系统。所有数据均取自第四版市场强化治疗医学(MIMIC-IV)数据库。通过回归分析确定院内死亡的独立危险因素。通过接收者操作特征(ROC)曲线评估五种评分系统的预测价值。Kaplan-Meier 曲线显示急性生理学评分 III(APSIII)对 SA-ARF 患者生存和预后的影响。决策曲线分析(DCA)确定了具有最高净临床获益的评分系统。ROC 曲线分析显示 APSIII(AUC:0.755,95%CI 0.714-0.768)和逻辑器官功能障碍系统(LODS)(AUC:0.731,95%CI 0.717-0.7745)优于简化急性生理学评分 II(SAPS II)(AUC:0.727,95%CI 0.713-0.741)、牛津急性疾病严重程度评分(OASIS)(AUC:0.706,95%CI 0.691-0.720)和序贯器官衰竭评估(SOFA)(AUC:0.606,95%CI 0.590-0.621),可用于评估院内死亡率。Kaplan-Meier 生存分析显示,APSIII 评分高的患者中位生存时间明显较差。DCA 曲线表明 APSIII 可能为患者提供更好的临床获益。我们证明 APSIII 评分是院内死亡率的一个优秀预测因子。